Evaluation reveals similar outcomes of immunotherapy in field versus out-of-field recurrences in endometrial and cervical cancers, suggesting efficacy in treated areas.
Immunotherapy remained active in tumors recurring within prior radiated fields. Outcomes were similar for in-field and out-of-field recurrences in EC and CC. Endometrial cancers recurring in-field had higher complete response rates. Cervical cancer outcomes were comparable across recurrence locations.
No takes yet. Share an insight, caveat, or question.
Chalif et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: